Poze Met Tablets 15mg/850mg

Pozemet (15mg/850mg) is an oral combination prescription tablet formulated to enhance glycemic control in adults with type 2 diabetes. Unlike medications that force the pancreas to secrete more insulin, Pozemet pairs pioglitazone (15mg), an insulin sensitizer, with metformin hydrochloride (850mg), a biguanide. Pioglitazone targets insulin resistance by making muscle and fat tissues more responsive to existing insulin. Metformin works complements this by significantly decreasing the amount of glucose the liver produces and releases, while slowing carbohydrate absorption in the intestines. Because neither agent actively triggers insulin oversecretion, Pozemet carries a much lower risk of sudden hypoglycemia compared to therapies containing sulfonylureas. For optimal safety and tolerance, take this tablet strictly with meals to minimize common metformin-related gastrointestinal side effects like bloating, nausea, or diarrhea. Crucially, the metformin component carries a rare but severe risk of lactic acidosis; therefore, Pozemet is strictly contraindicated in patients with severe kidney impairment. Additionally, due to pioglitazone’s propensity to cause fluid retention, patients must monitor for rapid weight gain or swollen ankles, which can worsen underlying heart failure.

Price: Rs. 110.00

• Manufacturer
  AGP Pharma
• Generic name
  Pioglitazone,Metformin HCl
• Pack size
  1 Box= 2 Strips | 1 Strip= 7 Tablets
• Availability
  In stock
• Prescription required
  Yes